The question of screening for prostate cancer has, since the advent of
prostate-specific antigen testing, become a major source of contentio
n. Important issues include: (1) should such screening become part of
routine health checks for men; (2) if routine screening is implemented
, at what age should it be started, and (3) can the early detection of
prostate cancer facilitated by such screening actually benefit the pa
tient in the long run? These were some of the topics put to the audien
ce and debated by the panel of experts in the discussion forum on scre
ening.